Which has the lower trailing P/E, BMY or SYK?

BMY has the lower trailing P/E: BMY trades at 14.12 and SYK at 29.21. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or SYK?

Over the past five years, SYK grew revenue faster — BMY at a 2.08% CAGR versus SYK at 9.72%.

Does BMY or SYK pay a bigger dividend?

BMY yields 3.94% and SYK yields 1.26% based on trailing dividends and the latest price.

Is BMY or SYK more profitable?

BMY runs the higher net margin — BMY at 18.87% versus SYK at 14.43%.

How have BMY and SYK total returns compared?

Over the past 10 years, BMY delivered 4.99% and SYK delivered 10.77% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Stryker Corporation (SYK)

A side-by-side comparison of Bristol-Myers Squibb Company and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.94B

$64.10HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

SYK

Stryker Corporation

$108.06B

$281.87HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

Total return — BMY vs SYK

growth of $100 · dividends reinvested · last 10y

BMY +60.1% (+4.8%/yr)SYK +169.1% (+10.4%/yr)SYK compounded faster over this window

BMY SYK

BMY vs SYK: by the numbers

•BMY is the larger company ($130.94B vs $108.06B market cap).
•BMY trades at the lower trailing earnings multiple (14.12 vs 29.21 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 14.43% net margin).
•SYK grew revenue faster over the past five years (9.72% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.94% vs 1.26%).

Metrics side by side

Valuation

Metric	BMY	SYK
P/E ratio	14.12	29.21
Forward P/E	9.25	18.78
P/S ratio	2.66	4.18
P/B ratio	5.87	4.50
EV / EBITDA	9.76	17.24
FCF yield	8.74%	4.35%

Profitability

Metric	BMY	SYK
Gross margin	70.16%	65.17%
Operating margin	28.27%	22.03%
Net margin	18.87%	14.43%
ROE	41.59%	15.55%
ROIC	15.47%	9.82%

Dividends

Metric	BMY	SYK
Dividend yield	3.94%	1.26%
Payout ratio	55.29%	36.06%

Growth (annualized)

Metric	BMY	SYK
Revenue CAGR (5Y)	2.08%	9.72%
EPS CAGR (5Y)	9.38%	14.79%
FCF CAGR (5Y)	-0.95%	9.60%
Total return CAGR (5Y)	4.35%	1.16%

Frequently asked

Which has the lower trailing P/E, BMY or SYK?: BMY has the lower trailing P/E: BMY trades at 14.12 and SYK at 29.21. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or SYK?: Over the past five years, SYK grew revenue faster — BMY at a 2.08% CAGR versus SYK at 9.72%.
Does BMY or SYK pay a bigger dividend?: BMY yields 3.94% and SYK yields 1.26% based on trailing dividends and the latest price.
Is BMY or SYK more profitable?: BMY runs the higher net margin — BMY at 18.87% versus SYK at 14.43%.
How have BMY and SYK total returns compared?: Over the past 10 years, BMY delivered 4.99% and SYK delivered 10.77% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full SYK analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Stryker P/E ratio Bristol-Myers Squibb dividend yield Stryker dividend yield Bristol-Myers Squibb ROE Stryker ROE Bristol-Myers Squibb operating margin Stryker operating margin Bristol-Myers Squibb revenue growth Stryker revenue growth Bristol-Myers Squibb free cash flow Stryker free cash flow

Bristol-Myers Squibb & Stryker appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.